title: Responding to the evidence for the management of severe malaria.
authors.forename: Nathan P
authors.initials: NP
authors.lastname: Ford
authors.forename: Martin
authors.initials: M
authors.lastname: de Smet
authors.forename: Kavitha
authors.initials: K
authors.lastname: Kolappa
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: White
mesh_terms: D000962:Antimalarials / Q000600:supply & distribution / Q000627:therapeutic use*; D037621:Artemisinins / Q000627:therapeutic use*; D000077332:Artesunate; D016638:Critical Illness; D055317:Evidence-Based Practice; D017048:Health Care Costs; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D033181:Information Dissemination; D008288:Malaria / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D011803:Quinine / Q000627:therapeutic use; D014146:Training Support; D014944:World Health Organization
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D000077332:Artesunate; D011803:Quinine